TOKYO–(BUSINESS WIRE)–Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announced that the Paradise™ Ultrasound Renal Denervation (uRDN) system has received approval for manufacturing and marketing in Japan for the treatment of resistant hypertension on August 25. This marks the first approval in the country for a medical device indicated for the disease. The Paradise uRDN system was developed by Recor Medical, Inc., a U.S.-based subsidiary of Otsuka Medical Devices. This approval i